clinical trial · NCT07442006
Glycemic Variability of Combination Therapies in T2DM
JW Pharmaceutical·phase4·recruiting·n = 178
Type 2 Diabetes Mellitus (T2DM)Empagliflozin/MetforminAnagliptinMetforminEmpagliflozin/Linagliptin
brief summary
Glycemic Variability of Combination Therapies in T2DM
started
Oct 29, 2025
primary completion
Mar 31, 2027
completion
Mar 31, 2027
last updated
Mar 2, 2026
detailed description
A multicenter study to evaluate efficacy and safety
official title
A Multicenter Study to Evaluate Efficacy and Safety
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol